Lewy Body Dementia Market Report 2026
Download Free Sample Buy Now
Lewy Body Dementia Market Global Report 2026 Market Report Infographic Image

Published : February 2026

Pages : 175

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Lewy Body Dementia Market Report 2026

Global Outlook – By Diagnosis (Clinical Diagnosis, Biomarker-Based Diagnosis), By Medication (Cholinesterase Inhibitors, Antipsychotics, Antidepressants, Other Medications), By End-User (Hospitals, Specialty Clinics, Long-Term Care Facilities, Other End-Users) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
Purchase This Report Download Sample PDF
Item added to cart!

Lewy Body Dementia Market Overview

• Lewy Body Dementia market size has reached to $1.2 billion in 2025

• Expected to grow to $1.69 billion in 2030 at a compound annual growth rate (CAGR) of 6.9%

• Growth Driver: Rising Prevalence Of Brain-Related Disorders Driving The Market Growth

• Market Trend: Research Investments Driving Advancements In Lewy Body Dementia Treatment

• North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Lewy Body Dementia Market?

Lewy body dementia (LBD) is a neurodegenerative condition caused by abnormal protein deposits in the brain, impacting cognition, movement, and behavior. This results in a gradual decline in both mental and physical abilities, with symptoms including memory loss, hallucinations, tremors, and motor difficulties. Effective management is essential to address the cognitive and physical challenges associated with the disorder.

The main diagnosis types of lewy body dementia are clinical diagnosis and biomarker-based diagnosis. Clinical diagnosis involves identifying diseases like Lewy body dementia based on medical history, symptoms, and physical exams, aiding early recognition and treatment. It is treated with various medications, such as cholinesterase inhibitors, antipsychotics, antidepressants, and others, and used by various end-users, including hospitals, specialty clinics, long-term care facilities, and others.

Lewy Body Dementia Market Global Report 2026 Market Report bar graph

What Is The Lewy Body Dementia Market Size and Share 2026?

The lewy body dementia market size has grown strongly in recent years. It will grow from $1.2 billion in 2025 to $1.29 billion in 2026 at a compound annual growth rate (CAGR) of 7.2%. The growth in the historic period can be attributed to aging population growth, increased recognition of dementia subtypes, rising use of neurological examinations, expansion of hospital-based diagnosis, growing clinical focus on cognitive decline.

What Is The Lewy Body Dementia Market Growth Forecast?

The lewy body dementia market size is expected to see strong growth in the next few years. It will grow to $1.69 billion in 2030 at a compound annual growth rate (CAGR) of 6.9%. The growth in the forecast period can be attributed to improving diagnostic accuracy, rising burden of chronic neurological diseases, expanding specialty clinic networks, increased caregiver and patient support programs, higher healthcare spending on dementia care. Major trends in the forecast period include rising prevalence of neurodegenerative disorders, increasing awareness and early recognition of lbd, growing demand for accurate differential diagnosis, expansion of symptom-specific drug utilization, rising need for long-term care and disease management.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us

Global Lewy Body Dementia Market Segmentation

1) By Diagnosis: Clinical Diagnosis, Biomarker-Based Diagnosis

2) By Medication: Cholinesterase Inhibitors, Antipsychotics, Antidepressants, Other Medications

3) By End-User: Hospitals, Specialty Clinics, Long-Term Care Facilities, Other End-Users

Subsegments:

1) By Clinical Diagnosis: Neuropsychological Testing, Neurological Examination, Medical History Review, Cognitive Function Assessment

2) By Biomarker-Based Diagnosis: Cerebrospinal Fluid (CSF) Biomarkers, Imaging Biomarkers (PET, MRI)

What Is The Driver Of The Lewy Body Dementia Market?

The rise in the prevalence of brain-related disorders is expected to propel the growth of the lewy body dementia market going forward. Brain-related disorders refer to a range of conditions affecting the brain’s structure and function, leading to cognitive decline, memory loss, and behavioral changes. The prevalence of brain-related disorders is increasing due to factors such as aging, genetic predisposition, and environmental influences. The increasing prevalence of brain-related disorders boosts the demand for better treatments and early detection for lewy body dementia, which in turn drives research, funding, and innovation, leading to faster advancements in diagnosis and therapy for LBD. For instance, in October 2023, according to the World Federation of Neurology, the UK-based association of national neurological societies, more than 40% of the global population is affected by neurological conditions, with this burden expected to almost double by 2050. Therefore, the rise in the prevalence of brain-related disorders will drive the growth of the lewy body dementia industry.

Key Players In The Global Lewy Body Dementia Market

Major companies operating in the lewy body dementia market are Eli Lilly and Company, Mayo Foundation for Medical Education and Research, Eisai Co. Ltd., Sumitomo Dainippon Pharma Co. Ltd., Georgetown University Medical Center, Alzheimer's Society, BioArctic AB, Annovis Bio Inc., Sun Pharma Advanced Research Company Limited, Voyager Therapeutics Inc., Cognition Therapeutics, Athira Pharma, Allergan plc, Inhibikase Therapeutics, CuraSen Therapeutics Inc., CervoMed Inc., AC Immune SA, ProMIS Neurosciences Inc., Aptinyx Inc., EIP Pharma Inc.

Global Lewy Body Dementia Market Trends and Insights

Major companies operating in the lewy body dementia market are focusing on research investment to develop more effective neurodegenerative treatments. Research investment involves dedicating financial resources, time, and effort to scientific and technological studies aimed at uncovering new insights, developing innovative solutions, or enhancing current practices. It supports the exploration of diseases and the creation of new medications, all with the ultimate goal of improving patient outcomes. For instance, in March 2023, the National Institute on Aging, a US-based government agency, awarded $21 million to support drug development research for Lewy Body Dementia (LBD). Researchers at the University of Miami Miller School of Medicine are initiating a Phase 2b study of neflamapimod following encouraging early results.

Need data on a specific region in this market?
Request Regional Data

What Are Latest Mergers And Acquisitions In The Lewy Body Dementia Market?

In March 2023, CND Life Sciences, a US-based developer of highly accurate skin-based tests to help clinicians diagnose dementia with Lewy bodies, partnered with Beth Israel Deaconess Medical Center (BIDMC) to enhance its skin-based diagnostic tool for neurodegenerative diseases. This partnership aims to leverage advanced technology to improve the detection of misfolded alpha-synuclein proteins and explore additional protein markers associated with other neurodegenerative disorders, ultimately facilitating more accurate diagnoses and better patient outcomes as new therapies emerge. Beth Israel Deaconess Medical Center (BIDMC) is a US-based company specializing in diagnosing and treating conditions such as Lewy body disease.

Regional Outlook

North America was the largest region in the lewy body dementia market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Lewy Body Dementia Market?

The lewy body dementia market consists of revenues earned by entities by providing services such as cognitive and motor function therapies, pharmaceutical treatments, and physical therapies. The market value includes the value of related goods sold by the service provider or included within the service offering. The lewy body dementia market also includes sales of sleep aids, mood stabilizers, and anxiolytics. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Lewy Body Dementia Market Report 2026?

The lewy body dementia market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the lewy body dementia industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abdul Wasay

Lewy Body Dementia Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2026 $1.29 billion
Revenue Forecast In 2035 $1.69 billion
Growth Rate CAGR of 7.2% from 2026 to 2035
Base Year For Estimation 2025
Actual Estimates/Historical Data 2020-2025
Forecast Period 2026 - 2030 - 2035
Market Representation Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered Diagnosis, Medication, End-User
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled Eli Lilly and Company, Mayo Foundation for Medical Education and Research, Eisai Co. Ltd., Sumitomo Dainippon Pharma Co. Ltd., Georgetown University Medical Center, Alzheimer's Society, BioArctic AB, Annovis Bio Inc., Sun Pharma Advanced Research Company Limited, Voyager Therapeutics Inc., Cognition Therapeutics, Athira Pharma, Allergan plc, Inhibikase Therapeutics, CuraSen Therapeutics Inc., CervoMed Inc., AC Immune SA, ProMIS Neurosciences Inc., Aptinyx Inc., EIP Pharma Inc.
Customization ScopeRequest for Customization
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Lewy Body Dementia Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Lewy Body Dementia Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Lewy Body Dementia Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Lewy Body Dementia Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Artificial Intelligence & Autonomous Intelligence

4.1.2 Biotechnology, Genomics & Precision Medicine

4.1.3 Digitalization, Cloud, Big Data & Cybersecurity

4.1.4 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems

4.1.5 Immersive Technologies (Ar/Vr/Xr) & Digital Experiences

4.2. Major Trends

4.2.1 Rising Prevalence Of Neurodegenerative Disorders

4.2.2 Increasing Awareness And Early Recognition Of Lbd

4.2.3 Growing Demand For Accurate Differential Diagnosis

4.2.4 Expansion Of Symptom-Specific Drug Utilization

4.2.5 Rising Need For Long-Term Care And Disease Management

5. Lewy Body Dementia Market Analysis Of End Use Industries

5.1 Hospitals

5.2 Specialty Clinics

5.3 Long-Term Care Facilities

5.4 Neurology Centers

5.5 Diagnostic Imaging Centers

6. Lewy Body Dementia Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Lewy Body Dementia Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Lewy Body Dementia PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Lewy Body Dementia Market Size, Comparisons And Growth Rate Analysis

7.3. Global Lewy Body Dementia Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Lewy Body Dementia Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Lewy Body Dementia Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Lewy Body Dementia Market Segmentation

9.1. Global Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Clinical Diagnosis, Biomarker-Based Diagnosis

9.2. Global Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Cholinesterase Inhibitors, Antipsychotics, Antidepressants, Other Medications

9.3. Global Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospitals, Specialty Clinics, Long-Term Care Facilities, Other End-Users

9.4. Global Lewy Body Dementia Market, Sub-Segmentation Of Clinical Diagnosis, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Neuropsychological Testing, Neurological Examination, Medical History Review, Cognitive Function Assessment

9.5. Global Lewy Body Dementia Market, Sub-Segmentation Of Biomarker-Based Diagnosis, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Cerebrospinal Fluid (CSF) Biomarkers, Imaging Biomarkers (PET, MRI)

10. Lewy Body Dementia Market Regional And Country Analysis

10.1. Global Lewy Body Dementia Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Lewy Body Dementia Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Lewy Body Dementia Market

11.1. Asia-Pacific Lewy Body Dementia Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Lewy Body Dementia Market, Segmentation By Diagnosis, Segmentation By Medication, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Lewy Body Dementia Market

12.1. China Lewy Body Dementia Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Lewy Body Dementia Market, Segmentation By Diagnosis, Segmentation By Medication, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Lewy Body Dementia Market

13.1. India Lewy Body Dementia Market, Segmentation By Diagnosis, Segmentation By Medication, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Lewy Body Dementia Market

14.1. Japan Lewy Body Dementia Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

14.2. Japan Lewy Body Dementia Market, Segmentation By Diagnosis, Segmentation By Medication, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Lewy Body Dementia Market

15.1. Australia Lewy Body Dementia Market, Segmentation By Diagnosis, Segmentation By Medication, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Lewy Body Dementia Market

16.1. Indonesia Lewy Body Dementia Market, Segmentation By Diagnosis, Segmentation By Medication, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Lewy Body Dementia Market

17.1. South Korea Lewy Body Dementia Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

17.2. South Korea Lewy Body Dementia Market, Segmentation By Diagnosis, Segmentation By Medication, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Lewy Body Dementia Market

18.1. Taiwan Lewy Body Dementia Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

18.2. Taiwan Lewy Body Dementia Market, Segmentation By Diagnosis, Segmentation By Medication, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Lewy Body Dementia Market

19.1. South East Asia Lewy Body Dementia Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

19.2. South East Asia Lewy Body Dementia Market, Segmentation By Diagnosis, Segmentation By Medication, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Lewy Body Dementia Market

20.1. Western Europe Lewy Body Dementia Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

20.2. Western Europe Lewy Body Dementia Market, Segmentation By Diagnosis, Segmentation By Medication, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Lewy Body Dementia Market

21.1. UK Lewy Body Dementia Market, Segmentation By Diagnosis, Segmentation By Medication, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Lewy Body Dementia Market

22.1. Germany Lewy Body Dementia Market, Segmentation By Diagnosis, Segmentation By Medication, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Lewy Body Dementia Market

23.1. France Lewy Body Dementia Market, Segmentation By Diagnosis, Segmentation By Medication, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Lewy Body Dementia Market

24.1. Italy Lewy Body Dementia Market, Segmentation By Diagnosis, Segmentation By Medication, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Lewy Body Dementia Market

25.1. Spain Lewy Body Dementia Market, Segmentation By Diagnosis, Segmentation By Medication, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Lewy Body Dementia Market

26.1. Eastern Europe Lewy Body Dementia Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

26.2. Eastern Europe Lewy Body Dementia Market, Segmentation By Diagnosis, Segmentation By Medication, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Lewy Body Dementia Market

27.1. Russia Lewy Body Dementia Market, Segmentation By Diagnosis, Segmentation By Medication, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Lewy Body Dementia Market

28.1. North America Lewy Body Dementia Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

28.2. North America Lewy Body Dementia Market, Segmentation By Diagnosis, Segmentation By Medication, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Lewy Body Dementia Market

29.1. USA Lewy Body Dementia Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

29.2. USA Lewy Body Dementia Market, Segmentation By Diagnosis, Segmentation By Medication, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Lewy Body Dementia Market

30.1. Canada Lewy Body Dementia Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

30.2. Canada Lewy Body Dementia Market, Segmentation By Diagnosis, Segmentation By Medication, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Lewy Body Dementia Market

31.1. South America Lewy Body Dementia Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

31.2. South America Lewy Body Dementia Market, Segmentation By Diagnosis, Segmentation By Medication, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Lewy Body Dementia Market

32.1. Brazil Lewy Body Dementia Market, Segmentation By Diagnosis, Segmentation By Medication, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Lewy Body Dementia Market

33.1. Middle East Lewy Body Dementia Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

33.2. Middle East Lewy Body Dementia Market, Segmentation By Diagnosis, Segmentation By Medication, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Lewy Body Dementia Market

34.1. Africa Lewy Body Dementia Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

34.2. Africa Lewy Body Dementia Market, Segmentation By Diagnosis, Segmentation By Medication, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Lewy Body Dementia Market Regulatory and Investment Landscape

36. Lewy Body Dementia Market Competitive Landscape And Company Profiles

36.1. Lewy Body Dementia Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Lewy Body Dementia Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Lewy Body Dementia Market Company Profiles

36.3.1. Eli Lilly and Company Overview, Products and Services, Strategy and Financial Analysis

36.3.2. Mayo Foundation for Medical Education and Research Overview, Products and Services, Strategy and Financial Analysis

36.3.3. Eisai Co. Ltd. Overview, Products and Services, Strategy and Financial Analysis

36.3.4. Sumitomo Dainippon Pharma Co. Ltd. Overview, Products and Services, Strategy and Financial Analysis

36.3.5. Georgetown University Medical Center Overview, Products and Services, Strategy and Financial Analysis

37. Lewy Body Dementia Market Other Major And Innovative Companies

Alzheimer's Society, BioArctic AB, Annovis Bio Inc., Sun Pharma Advanced Research Company Limited, Voyager Therapeutics Inc., Cognition Therapeutics, Athira Pharma, Allergan plc, Inhibikase Therapeutics, CuraSen Therapeutics Inc., CervoMed Inc., AC Immune SA, ProMIS Neurosciences Inc., Aptinyx Inc., EIP Pharma Inc.

38. Global Lewy Body Dementia Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Lewy Body Dementia Market

40. Lewy Body Dementia Market High Potential Countries, Segments and Strategies

40.1 Lewy Body Dementia Market In 2030 - Countries Offering Most New Opportunities

40.2 Lewy Body Dementia Market In 2030 - Segments Offering Most New Opportunities

40.3 Lewy Body Dementia Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Lewy Body Dementia Market, Overview Of Key Products - Product Examples
  • Table 2: Global Lewy Body Dementia Market Attractiveness, Factor-Wise Evaluation
  • Table 3: Global Lewy Body Dementia Market, Supply Chain Analysis
  • Table 4: Global Lewy Body Dementia Market, Major Raw Material Providers
  • Table 5: Global Lewy Body Dementia Market, Major Resource Providers
  • Table 6: Global Lewy Body Dementia Market, Major Manufacturers (Suppliers)
  • Table 7: Global Lewy Body Dementia Market, Major Distributors And Channel Partners
  • Table 8: Global Lewy Body Dementia Market, Key Technologies & Future Trends
  • Table 9: Global Lewy Body Dementia Market, Major Trends
  • Table 10: Global Lewy Body Dementia Market, Major End Users
  • Table 11: Global Lewy Body Dementia Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Table 12: Global Lewy Body Dementia Historic Market Growth, 2020-2025, $ Billion
  • Table 13: Global Lewy Body Dementia Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Table 14: Global Lewy Body Dementia Market - TAM, US$ Billion, 2025
  • Table 15: Global Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 16: Global Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 17: Global Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 18: Global Lewy Body Dementia Market, Sub-Segmentation Of Clinical Diagnosis, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 19: Global Lewy Body Dementia Market, Sub-Segmentation Of Biomarker-Based Diagnosis, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 20: Global Lewy Body Dementia Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 21: Global Lewy Body Dementia Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 22: Asia-Pacific, Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 23: Asia-Pacific, Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 24: Asia-Pacific, Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 25: China, Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 26: China, Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 27: China, Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 28: India, Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 29: India, Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 30: India, Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 31: Japan, Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 32: Japan, Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 33: Japan, Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 34: Australia, Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 35: Australia, Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 36: Australia, Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 37: Indonesia, Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 38: Indonesia, Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 39: Indonesia, Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 40: South Korea, Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 41: South Korea, Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 42: South Korea, Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 43: Taiwan, Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 44: Taiwan, Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 45: Taiwan, Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 46: South East Asia, Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 47: South East Asia, Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 48: South East Asia, Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 49: Western Europe, Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 50: Western Europe, Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 51: Western Europe, Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 52: UK, Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 53: UK, Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 54: UK, Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 55: Germany, Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 56: Germany, Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 57: Germany, Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 58: France, Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 59: France, Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 60: France, Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 61: Italy, Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 62: Italy, Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 63: Italy, Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 64: Spain, Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 65: Spain, Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 66: Spain, Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 67: Eastern Europe, Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 68: Eastern Europe, Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 69: Eastern Europe, Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 70: Russia, Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 71: Russia, Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 72: Russia, Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 73: North America, Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 74: North America, Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 75: North America, Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 76: USA, Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 77: USA, Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 78: USA, Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 79: Canada, Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 80: Canada, Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 81: Canada, Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 82: South America, Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 83: South America, Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 84: South America, Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 85: Brazil, Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 86: Brazil, Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 87: Brazil, Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 88: Middle East, Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 89: Middle East, Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 90: Middle East, Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 91: Africa, Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 92: Africa, Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 93: Africa, Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 94: Global Lewy Body Dementia Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Table 95: Global Lewy Body Dementia Market - Company Scoring Matrix
  • Table 96: Eli Lilly and Company Financial Performance
  • Table 97: Mayo Foundation for Medical Education and Research Financial Performance
  • Table 98: Eisai Co. Ltd. Financial Performance
  • Table 99: Sumitomo Dainippon Pharma Co. Ltd. Financial Performance
  • Table 100: Georgetown University Medical Center Financial Performance
  • Table 101: Global Lewy Body Dementia Market, Competitive Benchmarking (In USD Billions)
  • Table 102: Global Lewy Body Dementia Market, Competitive Dashboard
  • Table 103: Global Lewy Body Dementia Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Table 104: Global, Lewy Body Dementia Market Size Gain ($ Billion), Segmentation By Diagnosis, 2025 – 2030
  • Table 105: Global, Lewy Body Dementia Market Size Gain ($ Billion), Segmentation By Medication, 2025 – 2030
  • Table 106: Global, Lewy Body Dementia Market Size Gain ($ Billion), Segmentation By End-User, 2025 – 2030

List Of Figures

    Figure 1: Global Lewy Body Dementia Market, Overview Of Key Products - Product Examples
  • Figure 2: Global Lewy Body Dementia Market Attractiveness, Factor-Wise Evaluation
  • Figure 3: Global Lewy Body Dementia Market, Supply Chain Analysis
  • Figure 4: Global Lewy Body Dementia Market, Major Raw Material Providers
  • Figure 5: Global Lewy Body Dementia Market, Major Resource Providers
  • Figure 6: Global Lewy Body Dementia Market, Major Manufacturers (Suppliers)
  • Figure 7: Global Lewy Body Dementia Market, Major Distributors And Channel Partners
  • Figure 8: Global Lewy Body Dementia Market, Key Technologies & Future Trends
  • Figure 9: Global Lewy Body Dementia Market, Major Trends
  • Figure 10: Global Lewy Body Dementia Market, Major End Users
  • Figure 11: Global Lewy Body Dementia Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Figure 12: Global Lewy Body Dementia Historic Market Growth, 2020-2025, $ Billion
  • Figure 13: Global Lewy Body Dementia Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Figure 14: Global Lewy Body Dementia Market - TAM, US$ Billion, 2025
  • Figure 15: Global Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 16: Global Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 17: Global Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 18: Global Lewy Body Dementia Market, Sub-Segmentation Of Clinical Diagnosis, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 19: Global Lewy Body Dementia Market, Sub-Segmentation Of Biomarker-Based Diagnosis, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 20: Global Lewy Body Dementia Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 21: Global Lewy Body Dementia Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 22: Asia-Pacific, Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 23: Asia-Pacific, Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 24: Asia-Pacific, Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 25: China, Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 26: China, Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 27: China, Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 28: India, Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 29: India, Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 30: India, Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 31: Japan, Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 32: Japan, Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 33: Japan, Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 34: Australia, Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 35: Australia, Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 36: Australia, Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 37: Indonesia, Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 38: Indonesia, Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 39: Indonesia, Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 40: South Korea, Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 41: South Korea, Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 42: South Korea, Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 43: Taiwan, Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 44: Taiwan, Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 45: Taiwan, Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 46: South East Asia, Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 47: South East Asia, Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 48: South East Asia, Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 49: Western Europe, Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 50: Western Europe, Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 51: Western Europe, Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 52: UK, Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 53: UK, Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 54: UK, Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 55: Germany, Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 56: Germany, Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 57: Germany, Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 58: France, Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 59: France, Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 60: France, Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 61: Italy, Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 62: Italy, Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 63: Italy, Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 64: Spain, Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 65: Spain, Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 66: Spain, Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 67: Eastern Europe, Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 68: Eastern Europe, Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 69: Eastern Europe, Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 70: Russia, Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 71: Russia, Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 72: Russia, Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 73: North America, Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 74: North America, Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 75: North America, Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 76: USA, Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 77: USA, Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 78: USA, Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 79: Canada, Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 80: Canada, Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 81: Canada, Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 82: South America, Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 83: South America, Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 84: South America, Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 85: Brazil, Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 86: Brazil, Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 87: Brazil, Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 88: Middle East, Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 89: Middle East, Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 90: Middle East, Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 91: Africa, Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 92: Africa, Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 93: Africa, Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 94: Global Lewy Body Dementia Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Figure 95: Global Lewy Body Dementia Market - Company Scoring Matrix
  • Figure 96: Eli Lilly and Company Financial Performance
  • Figure 97: Mayo Foundation for Medical Education and Research Financial Performance
  • Figure 98: Eisai Co. Ltd. Financial Performance
  • Figure 99: Sumitomo Dainippon Pharma Co. Ltd. Financial Performance
  • Figure 100: Georgetown University Medical Center Financial Performance
  • Figure 101: Global Lewy Body Dementia Market, Competitive Benchmarking (In USD Billions)
  • Figure 102: Global Lewy Body Dementia Market, Competitive Dashboard
  • Figure 103: Global Lewy Body Dementia Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Figure 104: Global, Lewy Body Dementia Market Size Gain ($ Billion), Segmentation By Diagnosis, 2025 – 2030
  • Figure 105: Global, Lewy Body Dementia Market Size Gain ($ Billion), Segmentation By Medication, 2025 – 2030
  • Figure 106: Global, Lewy Body Dementia Market Size Gain ($ Billion), Segmentation By End-User, 2025 – 2030

Global Acute Care Telemedicine Market Forecast to Reach $66.59 Billion by 2029, Driven by 17.7% CAGR

Read More About Global Acute Care Telemedicine Market Forecast to Reach $66.59 Billion by 2029, Driven by 17.7% CAGR

2025–2029 Assistive Technology For Low Vision Market Outlook: Regional Trends and Growth Forecast

Read More About 2025–2029 Assistive Technology For Low Vision Market Outlook: Regional Trends and Growth Forecast

Global Biotechnology And Pharmaceutical Services Outsourcing Market Forecast to Reach $94.91 Billion by 2029, Driven by 7.2% CAGR

Read More About Global Biotechnology And Pharmaceutical Services Outsourcing Market Forecast to Reach $94.91 Billion by 2029, Driven by 7.2% CAGR

Cancer Treatment Facilities Market Revenue Outlook: Strategic Insights and Forecast to 2029

Read More About Cancer Treatment Facilities Market Revenue Outlook: Strategic Insights and Forecast to 2029

CAGR of 10.4% Projected for Catastrophic Antiphospholipid Syndrome Market From 2025 to 2029

Read More About CAGR of 10.4% Projected for Catastrophic Antiphospholipid Syndrome Market From 2025 to 2029

Latest Market Developments in Clinical Risk Grouping Solution Industry: Forecast 2025–2029

Read More About Latest Market Developments in Clinical Risk Grouping Solution Industry: Forecast 2025–2029

2025–2029 Clinical Trial Investigative Site Network Market Outlook: Regional Trends and Growth Forecast

Read More About 2025–2029 Clinical Trial Investigative Site Network Market Outlook: Regional Trends and Growth Forecast

Future Demand and Leading Companies Shaping the Common Cold Market to 2029

Read More About Future Demand and Leading Companies Shaping the Common Cold Market to 2029

Lewy Body Dementia Treatment Market Report 2026 - Global Outlook – By Drug Type (Antidepressants, Carbidopa-Levodopa, Cholinesterase Inhibitors), By Distribution Channel (Hospitals Pharmacies, Retail Pharmacies, Online P...

Alzheimer's Drugs Market Report 2026 - Global Outlook – By Drugs (Donepezil, Rivastigmine, Galantamine, Memantine), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), By Application (Early To ...

Alzheimer's Drugs Market Report 2026 - Global Outlook – By Drugs (Donepezil, Rivastigmine, Galantamine, Memantine), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), By Application (Early To ...

Elderly Care Market Report 2026 - Global Outlook – By Type (Independent Community Living, Assisted Living, Nursing, In-Home Care, Daycare, Hybrid Care, Palliative Care), By Term (Short-Term, Long-Term), By Application (H...

Muscle Wasting Disorders Market Report 2026 - Global Outlook – By Treatment Type (Medications, Physical Therapy, Nutritional Therapy, Surgery, Gene Therapy, Other Treatment Types), By Disorder Type (Muscular Dystrophy, A...

Rare Neurological Disease Treatment Market Report 2026 - Global Outlook – By Drug Type (Biologics, Small Molecules), By Therapy (Cognitive Behavioral Therapy, Interpersonal Psychotherapy, Disease-Modifying Neurological T...

Smart Pillow Market Report 2026 - Global Outlook – By Product Type (Anti-Snoring Smart Pillows, Sleep-Tracking Smart Pillows, Thermo-Regulating Smart Pillows, Audio-Enabled Smart Pillows, Multifunctional Smart Pillows), ...

Progressive Ataxia And Weakness Disorders Market Report 2026 - Global Outlook – By Type (Progressive Ataxia, Progressive Weakness Disorders), By Technology (Small Molecule, Monoclonal Antibody, Other Technology), By Dist...

Frequently Asked Questions

The Lewy Body Dementia market was valued at $1.2 billion in 2025, increased to $1.29 billion in 2026, and is projected to reach $1.69 billion by 2030.

The global Lewy Body Dementia market is expected to grow at a CAGR of 6.9% from 2026 to 2035 to reach $1.69 billion by 2035.

Some Key Players in the Lewy Body Dementia market Include, Eli Lilly and Company, Mayo Foundation for Medical Education and Research, Eisai Co. Ltd., Sumitomo Dainippon Pharma Co. Ltd., Georgetown University Medical Center, Alzheimer's Society, BioArctic AB, Annovis Bio Inc., Sun Pharma Advanced Research Company Limited, Voyager Therapeutics Inc., Cognition Therapeutics, Athira Pharma, Allergan plc, Inhibikase Therapeutics, CuraSen Therapeutics Inc., CervoMed Inc., AC Immune SA, ProMIS Neurosciences Inc., Aptinyx Inc., EIP Pharma Inc. .

Major trend in this market includes: Research Investments Driving Advancements In Lewy Body Dementia Treatment. For further insights on this market. request a sample here

North America was the largest region in the lewy body dementia market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the lewy body dementia market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us